{"id":"https://openalex.org/W2078307249","doi":"https://doi.org/10.1007/s00213-010-1802-2","title":"The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice","display_name":"The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice","alternate_titles":[],"publication_year":2010,"publication_date":"2010-03-09","ids":{"openalex":"https://openalex.org/W2078307249","doi":"https://doi.org/10.1007/s00213-010-1802-2","mag":"2078307249","pmid":"https://pubmed.ncbi.nlm.nih.gov/20217053","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2855017"},"language":"en","primary_location":{"id":"doi:10.1007/s00213-010-1802-2","doi":"https://doi.org/10.1007/s00213-010-1802-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00213-010-1802-2","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs00213-010-1802-2.pdf","source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2078307249"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007%2Fs00213-010-1802-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077788483","display_name":"Hwei\u2010Hsien Chen","orcid":"https://orcid.org/0000-0002-8509-6448","observed_orcids":["https://orcid.org/0000-0002-8509-6448"]},"institutions":[{"id":"https://openalex.org/I189772984","display_name":"Tzu Chi University","ror":"https://ror.org/04ss1bw11","country_code":"TW","type":"education","lineage":["https://openalex.org/I189772984"]}],"countries":["TW"],"is_corresponding":true,"raw_author_name":"Hwei-Hsien Chen","raw_affiliation_strings":["Institute of Pharmacology and Toxicology, Tzu Chi University, 701, Section 3, Chung-Yang Road, Hualien, 970, Taiwan. hwei@mail.tcu.edu.tw","Institute of Pharmacology & Toxicology, Tzu Chi University, Hualien, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology and Toxicology, Tzu Chi University, 701, Section 3, Chung-Yang Road, Hualien, 970, Taiwan. hwei@mail.tcu.edu.tw","institution_ids":["https://openalex.org/I189772984"]},{"raw_affiliation_string":"Institute of Pharmacology & Toxicology, Tzu Chi University, Hualien, Taiwan","institution_ids":["https://openalex.org/I189772984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017333730","display_name":"Astrid K. Stoker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["NL","US"],"is_corresponding":false,"raw_author_name":"Astrid Stoker","raw_affiliation_strings":["Department of Psychiatry, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0603, USA","Department of Psychopharmacology, Utrecht Institute of Pharmaceutical Science, University of Utrecht, Utrecht, The Netherlands","University of California, San Diego","University of Utrecht"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0603, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Department of Psychopharmacology, Utrecht Institute of Pharmaceutical Science, University of Utrecht, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I193662353"]},{"raw_affiliation_string":"University of California, San Diego","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"University of Utrecht","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108474927","display_name":"Athina Markou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Athina Markou","raw_affiliation_strings":["Department of Psychiatry, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0603, USA","Department of Psychiatry, School of Medicine, University of California-San Diego, La Jolla, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093-0603, USA","institution_ids":["https://openalex.org/I36258959"]},{"raw_affiliation_string":"Department of Psychiatry, School of Medicine, University of California-San Diego, La Jolla, USA","institution_ids":["https://openalex.org/I36258959"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5077788483"],"corresponding_institution_ids":["https://openalex.org/I189772984"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":3.6129,"has_fulltext":true,"cited_by_count":48,"citation_normalized_percentile":{"value":0.92291426,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"209","issue":"4","first_page":"343","last_page":"350"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9384999871253967,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.027499999850988388,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12770","display_name":"Amino Acid Enzymes and Metabolism","score":0.018300000578165054,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metabotropic-glutamate-receptor-5","display_name":"metabotropic glutamate receptor 5","score":0.8980000019073486},{"id":"https://openalex.org/keywords/prepulse-inhibition","display_name":"prepulse inhibition","score":0.9539999961853027},{"id":"https://openalex.org/keywords/startle-response","display_name":"startle response","score":0.9480000138282776},{"id":"https://openalex.org/keywords/sarcosine","display_name":"sarcosine","score":0.9580000042915344},{"id":"https://openalex.org/keywords/n-acetylcysteine","display_name":"N-acetylcysteine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ly379268","display_name":"LY379268","score":0.9810000061988831},{"id":"https://openalex.org/keywords/glycine-transporter-1","display_name":"glycine transporter 1","score":0.7699999809265137},{"id":"https://openalex.org/keywords/slc7a11","display_name":"SLC7A11","score":0.7749999761581421},{"id":"https://openalex.org/keywords/extrasynaptic-glutamate","display_name":"extrasynaptic glutamate","score":0.9190000295639038},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.8220000267028809},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.4309999942779541},{"id":"https://openalex.org/keywords/antipsychotic-drug-development","display_name":"antipsychotic drug development","score":0.6790000200271606},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.8949999809265137}],"concepts":[{"id":"https://openalex.org/C49051014","wikidata":"https://www.wikidata.org/wiki/Q2033959","display_name":"Metabotropic glutamate receptor","level":4,"score":0.8700375556945801},{"id":"https://openalex.org/C41653306","wikidata":"https://www.wikidata.org/wiki/Q6589190","display_name":"Metabotropic glutamate receptor 5","level":5,"score":0.8384348154067993},{"id":"https://openalex.org/C119128870","wikidata":"https://www.wikidata.org/wiki/Q4859538","display_name":"Metabotropic glutamate receptor 2","level":5,"score":0.6690316796302795},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.6056760549545288},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.6017473936080933},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.556308925151825},{"id":"https://openalex.org/C87247309","wikidata":"https://www.wikidata.org/wiki/Q6590338","display_name":"Metabotropic glutamate receptor 7","level":5,"score":0.5558232665061951},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5498634576797485},{"id":"https://openalex.org/C207951395","wikidata":"https://www.wikidata.org/wiki/Q288431","display_name":"Metabotropic glutamate receptor 1","level":5,"score":0.5359393358230591},{"id":"https://openalex.org/C141421786","wikidata":"https://www.wikidata.org/wiki/Q1128897","display_name":"Prepulse inhibition","level":3,"score":0.5260821580886841},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5000450611114502},{"id":"https://openalex.org/C200385062","wikidata":"https://www.wikidata.org/wiki/Q6594119","display_name":"Metabotropic glutamate receptor 3","level":5,"score":0.43520379066467285},{"id":"https://openalex.org/C26702167","wikidata":"https://www.wikidata.org/wiki/Q901988","display_name":"Metabotropic receptor","level":4,"score":0.42516350746154785},{"id":"https://openalex.org/C56940625","wikidata":"https://www.wikidata.org/wiki/Q6589868","display_name":"Metabotropic glutamate receptor 6","level":5,"score":0.41247910261154175},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.38778156042099},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24701446294784546},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23295825719833374},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23183834552764893},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.22003722190856934},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.12272471189498901},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.07693392038345337}],"mesh":[{"descriptor_ui":"D000111","descriptor_name":"Acetylcysteine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000161","descriptor_name":"Acoustic Stimulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000704","descriptor_name":"Analysis of Variance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009433","descriptor_name":"Neural Inhibition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012521","descriptor_name":"Sarcosine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013216","descriptor_name":"Reflex, Startle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":true},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018094","descriptor_name":"Receptors, Metabotropic Glutamate","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018690","descriptor_name":"Excitatory Amino Acid Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D027182","descriptor_name":"Amino Acid Transport System y+","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D027182","descriptor_name":"Amino Acid Transport System y+","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false},{"descriptor_ui":"D050487","descriptor_name":"Glycine Plasma Membrane Transport Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D050487","descriptor_name":"Glycine Plasma Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064529","descriptor_name":"Receptor, Metabotropic Glutamate 5","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1007/s00213-010-1802-2","doi":"https://doi.org/10.1007/s00213-010-1802-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00213-010-1802-2","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs00213-010-1802-2.pdf","source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:20217053","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20217053","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2855017","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2855017/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology (Berl)","raw_type":"Text"},{"id":"pmh:oai:escholarship.org/ark:/13030/qt3td9b494","doi":null,"is_oa":false,"landing_page_url":"https://escholarship.org/uc/item/3td9b494","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Psychopharmacology, vol 209, iss 4","raw_type":"article"},{"id":"pmh:qt3td9b494","doi":null,"is_oa":false,"landing_page_url":"http://www.escholarship.org/uc/item/3td9b494","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Chen, Hwei-Hsien; Stoker, Astrid; &amp; Markou, Athina. (2010). The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice. Psychopharmacology, 209(4), pp 343-350. doi: 10.1007/s00213-010-1802-2. Retrieved from: http://www.escholarship.org/uc/item/3td9b494","raw_type":"article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.355.1401","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.355.1401","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/70/b2/Psychopharmacology_(Berl)_2010_May_10_209(4)_343-350.tar.gz","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1007/s00213-010-1802-2","doi":"https://doi.org/10.1007/s00213-010-1802-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00213-010-1802-2","pdf_url":"https://link.springer.com/content/pdf/10.1007%2Fs00213-010-1802-2.pdf","source":{"id":"https://openalex.org/S80334769","display_name":"Psychopharmacology","issn_l":"0033-3158","issn":["0033-3158","1432-2072"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7237028741","display_name":"Negative Symptoms of Schizophrenia: Animal Models","funder_award_id":"R01MH062527","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320321040","display_name":"National Science Council","ror":"https://ror.org/02kv4zf79"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320334746","display_name":"Institute of Materials Research and Engineering","ror":"https://ror.org/02sepg748"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2078307249.pdf","grobid_xml":"https://content.openalex.org/works/W2078307249.grobid-xml"},"referenced_works_count":57,"referenced_works":["https://openalex.org/W1508825618","https://openalex.org/W1510518012","https://openalex.org/W1557451274","https://openalex.org/W1571617145","https://openalex.org/W1656913045","https://openalex.org/W1716703308","https://openalex.org/W1904171769","https://openalex.org/W1963479676","https://openalex.org/W1965632303","https://openalex.org/W1966761076","https://openalex.org/W1966941161","https://openalex.org/W1968840456","https://openalex.org/W1969235249","https://openalex.org/W1974071870","https://openalex.org/W1987322407","https://openalex.org/W1988299084","https://openalex.org/W1989004477","https://openalex.org/W1990535802","https://openalex.org/W2001232602","https://openalex.org/W2003906510","https://openalex.org/W2005756201","https://openalex.org/W2008746956","https://openalex.org/W2017267321","https://openalex.org/W2018436424","https://openalex.org/W2022644899","https://openalex.org/W2028884770","https://openalex.org/W2034505327","https://openalex.org/W2034973586","https://openalex.org/W2035785231","https://openalex.org/W2036521491","https://openalex.org/W2036691985","https://openalex.org/W2044598463","https://openalex.org/W2044758888","https://openalex.org/W2046411639","https://openalex.org/W2048080687","https://openalex.org/W2050717159","https://openalex.org/W2051360697","https://openalex.org/W2067929856","https://openalex.org/W2071723486","https://openalex.org/W2077485423","https://openalex.org/W2078977508","https://openalex.org/W2081413793","https://openalex.org/W2084395458","https://openalex.org/W2084989539","https://openalex.org/W2087201853","https://openalex.org/W2090979638","https://openalex.org/W2097693079","https://openalex.org/W2100194652","https://openalex.org/W2104417933","https://openalex.org/W2110678771","https://openalex.org/W2114342445","https://openalex.org/W2115826405","https://openalex.org/W2129116806","https://openalex.org/W2142885788","https://openalex.org/W2147644350","https://openalex.org/W2159058915","https://openalex.org/W2167116111"],"related_works":["https://openalex.org/W2167116111","https://openalex.org/W1965632303","https://openalex.org/W2008746956","https://openalex.org/W2770191957","https://openalex.org/W1974071870","https://openalex.org/W2137464199","https://openalex.org/W2044598463","https://openalex.org/W2728852205","https://openalex.org/W2114342445"],"abstract_inverted_index":{"RATIONALE:":[0],"Mice":[1],"lacking":[2],"metabotropic":[3],"glutamate":[4,135,222,232],"receptors":[5,209],"5":[6],"(mGluR5)":[7],"exhibit":[8],"reduced":[9],"glutamatergic":[10,61],"function":[11],"and":[12,82,123,150,207,217],"behavioral":[13,237],"abnormalities,":[14],"including":[15],"deficits":[16,143,157,169],"in":[17,90,137,144,158,212],"prepulse":[18],"inhibition":[19],"(PPI)":[20],"of":[21,45,49,69,78,84,93,98,106,111,164,184,191,215,221],"the":[22,70,91,104,112,138,174,182,203,213,236],"startle":[23],"response":[24],"that":[25,38,59,128,181,202,219],"may":[26,39,234],"be":[27,40],"relevant":[28],"to":[29,102,133,166,189],"schizophrenia.":[30,94],"Thus,":[31],"these":[32],"mice":[33],"are":[34,210],"an":[35],"animal":[36],"model":[37],"used":[41],"for":[42],"preclinical":[43],"evaluation":[44],"potentially":[46],"new":[47],"classes":[48],"antipsychotic":[50],"compounds.":[51],"Recent":[52],"clinical":[53],"studies":[54],"have":[55],"suggested":[56],"several":[57],"compounds":[58],"modulate":[60],"transmission":[62],"through":[63],"distinct":[64],"mechanisms,":[65],"such":[66],"as":[67,87],"potentiation":[68],"N-methyl-D:":[71],"-aspartate":[72],"(NMDA)":[73],"receptor":[74],"glycine":[75,113],"site,":[76],"activation":[77,83,190,220],"group":[79,119,175,192,226],"II":[80,120,176,193,227],"mGluR,":[81],"glutamate-cysteine":[85],"antiporters,":[86],"being":[88],"efficacious":[89],"treatment":[92],"OBJECTIVES:":[95],"The":[96,162],"aim":[97],"this":[99],"work":[100],"is":[101],"evaluate":[103],"effects":[105,183],"sarcosine":[107],"(a":[108,118,125],"selective":[109],"inhibitor":[110],"transporter":[114],"1":[115],"[GlyT1]),":[116],"LY379268":[117],"mGluR":[121,177],"agonist),":[122],"N-acetylcysteine":[124,165,185],"cysteine":[126],"prodrug":[127],"indirectly":[129],"activates":[130],"cystine-glutamate":[131],"antiporters":[132],"increase":[134],"levels":[136],"extrasynaptic":[139],"space)":[140],"on":[141],"PPI":[142,156,168,216],"mGluR5":[145,159,206,241],"knockout":[146,160],"mice.":[147,161],"RESULTS:":[148],"Sarcosine":[149],"N-acetylcysteine,":[151],"but":[152],"not":[153,171,187],"LY379268,":[154],"ameliorated":[155],"ability":[163],"restore":[167],"was":[170],"blocked":[172],"by":[173,195,229],"antagonist":[178],"LY341495,":[179],"indicating":[180],"were":[186],"attributable":[188],"mGluRs":[194],"glutamate.":[196],"CONCLUSIONS:":[197],"These":[198],"findings":[199],"provide":[200],"evidence":[201],"interactions":[204],"between":[205],"NMDA":[208],"involved":[211],"regulation":[214],"suggest":[218],"receptors,":[223,228],"other":[224],"than":[225],"increased":[230],"endogenous":[231],"transmission,":[233],"ameliorate":[235],"abnormalities":[238],"associated":[239],"with":[240],"deficiency.":[242]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2078307249","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
